Did you know?

ChinaBio® Group is a consulting and advisory firm helping life science companies and investors achieve success in China. ChinaBio works with U.S., European and APAC companies and investors seeking partnerships, acquisitions, novel technologies and funding in China.  

Learn more >>

Free Newsletter

Have the latest stories on China's life science industry delivered to your inbox daily or weekly - free!

See preview >>

  Email address:
   

Fosun Bids $584 Million for Portuguese Healthcare Chain

publication date: Sep 30, 2014
Demonstrating its continuing interest in healthcare assets, Fosun International raised its offer to acquire Espirito Santo Saude, a Portuguese chain of hospitals clinics and nursing homes, to $584 million, making Fosun the current high bidder. The takeover battle for ESS remains open, and ESS is trading slightly above Fosun's 4.82 euros per share offer. Today, in other news, Fosun and its partners announced they have closed the $434 million take-private acquisition of Chindex, a chain of private China hospitals and clinics. More details....

Stock Symbol: (HK: 656)

Share this with colleagues:  


This article is available for purchase - please click here for details.

Sorry this page is available to subscribers only.
If you're not a subscriber why not subscribe today?

If you are already a subscriber, please login.

If you believe you should have received this message in error, please contact us.


 

To gain access to the members only content click here to subscribe.

You will be given immediate access to premium content on the site.

Upcoming Events

ChinaBio® Partnering Forum
September 10–11, 2024 | Shanghai, China
Register here

BIO-Europe®
November 4–6, 2024 | Stockholm, Sweden
Save €900 before September 13!
Register here

Biotech Showcase™
January 13–15, 2025 | San Francisco, CA
Save $600 before September 27!
Other Relevant Events

Antibody Engineering & Therapeutics Asia
October 21–23, 2024 | Kyoto, Japan
Save 30% with code CHINABIO30!
Register here